NCT02286817 · Interventional trial
Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder
Overall registry status Completed
Phase 1
Conditions Attention-deficit Hyperactivity Disorder (ADHD)
Delaware Valley sites
- Thomas Jefferson University, Clinical Research Unit · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory